Heart Test Laboratories Inc. Common Stock (HSCS) — Cash Flow-to-Debt Ratio
Heart Test Laboratories Inc. Common Stock (HSCS) has a Cash Flow-to-Debt Ratio of -0.33x as of April 2026, meaning its operating cash flow of $-1.68 Million could theoretically repay 0% of its total liabilities ($5.04 Million) in one year. See Heart Test Laboratories Inc. Common Stoc (HSCS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Heart Test Laboratories Inc. Common Stock Cash Flow-to-Debt Ratio (2020–2026)
Historical debt coverage capacity for Heart Test Laboratories Inc. Common Stock across 7 annual periods. See net asset quality index of Heart Test Laboratories Inc. Common Stoc to measure how much of total assets are equity-financed.
Annual Cash Flow-to-Debt Ratio for Heart Test Laboratories Inc. Common Stock (2020–2026)
Year-by-year debt coverage analysis for Heart Test Laboratories Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Heart Test Laboratories Inc. Common Stoc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.00x | $-7.43 Million | $5.04 Billion | ▲ +99.9% |
| 2025 | -1.85x | $-7.41 Million | $4.02 Million | ▲ +33.6% |
| 2024 | -2.78x | $-6.07 Million | $2.19 Million | ▼ -47.0% |
| 2023 | -1.89x | $-5.77 Million | $3.06 Million | ▼ -322.2% |
| 2022 | -0.45x | $-3.64 Million | $8.15 Million | ▲ +30.0% |
| 2021 | -0.64x | $-2.45 Million | $3.84 Million | ▲ +72.7% |
| 2020 | -2.34x | $-3.84 Million | $1.64 Million | — |